Mechanism
Autologous angiogenic cell precursor (ACP) therapy - blood-derived
Assets acting on this target.
- Class
- Autologous angiogenic cell precursor (ACP) therapy - blood-derived autologous progenitor cells, administered by intramuscular injection (Hemostemix proprietary cell-expansion platform)
- Pathway
- Therapeutic angiogenesis for no-option critical limb ischemia
- Notes
- original target text: Autologous angiogenic cell precursor (ACP) therapy - blood-derived autologous progenitor cells, administered by intramuscular injection (Hemostemix proprietary cell-expansion platform)
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.